Showing results (1121-1130 of 1,447) with videos related to
Sort By:
Pageof 145
Proteomics. Clinical Applications|December 8, 2010
Proneurotensin/neuromedin N secreted from small cell lung carcinoma cell lines as a potential tumor markerShun-Ichiro Ogura, Kumi Kaneko, Shoji Miyajima, et al.Proteomics. Clinical Applications|December 8, 2010
Proteomics and naturally occurring animal diseases: Opportunities for animal and human medicineMary K Doherty, Robert J Beynon, Phillip D WhitfieldProteomics. Clinical Applications|December 8, 2010
Phosphoproteomics: A possible route to novel biomarkers of breast cancerMetodi Metodiev, Louise AlldridgeProteomics. Clinical Applications|December 8, 2010
Ovarian cancer proteomics: Many technologies one goalKothandaraman Narasimhan, Zhao Changqing, Mahesh ChoolaniProteomics. Clinical Applications|December 8, 2010
Type 2 diabetes: Gaining insight into the disease process using proteomicsMichael Maris, Lut Overbergh, Chantal MathieuProteomics. Clinical Applications|December 8, 2010
Proteomic approaches for discovery of new targets for vaccine and therapeutics against visceral leishmaniasisShraddha Kumari, Awanish Kumar, Mukesh Samant, et al.Proteomics. Clinical Applications|December 8, 2010
Human pathogenic streptococcal proteomics and vaccine developmentJason N Cole, Anna Henningham, Christine M Gillen, et al.Proteomics. Clinical Applications|December 8, 2010
Clinical proteomics of the cerebrospinal fluid: Towards the discovery of new biomarkersStéphane Roche, Audrey Gabelle, Sylvain LehmannProteomics. Clinical Applications|December 8, 2010
Proteomics of human cerebral microdialysate: From detection of biomarkers to clinical applicationMartin H Maurer, Daniel Haux, Andreas W Unterberg, et al.Proteomics. Clinical Applications|December 8, 2010
Proteomics and genomics: A hypothesis-free approach to the study of the role of visceral adiposity in the pathogenesis of the polycystic ovary syndromeHéctor F Escobar-Morreale, María Insenser, Marta Cortón, et al.Pageof 145